Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Update Il y a 4 ans
Reference: NCT00483574

Woman and Man

Extract

This clinical trial will evaluate the safety of two injections of Menactra® Vaccine in subjects at 9 months and at 12 months of age when the second dose is given concomitantly with other pediatric vaccines routinely administered in the US. Safety Objective: To describe the safety profile of two doses of Menactra® Vaccine.


Inclusion criteria

  • Meningococcal Meningitis ,Measles ,Mumps ,Rubella ,varicella

Links